Fezakinumab

Fezakinumab is a human monoclonal antibody against interleukin-22, designed for the treatment of psoriasis and rheumatoid arthritis.

Wyeth discovered and initially developed the drug, and clinical development continued after that company was acquired by Pfizer. Fezakinumab, in combination with methotrexate, completed a phase II trial in rheumatoid arthritis, but data was not released. Development was discontinued in August 2011.

单词	Fezakinumab
释义	Fezakinumab 英语百科 Fezakinumab Fezakinumab is a human monoclonal antibody against interleukin-22, designed for the treatment of psoriasis and rheumatoid arthritis. Wyeth discovered and initially developed the drug, and clinical development continued after that company was acquired by Pfizer. Fezakinumab, in combination with methotrexate, completed a phase II trial in rheumatoid arthritis, but data was not released. Development was discontinued in August 2011.
随便看	Kefken Kefken Adasι Keflavik keflaviks Keflex Keflin Keflin,gentamicin,and carbenicillin Keflodin Keflor Keflordin kefloridin Kefocef Kefolor Keforal Kefspor KEFT Keftab keftabs Keftedes kefuffles kefyr Kefzol Kegalla Kegalla Dist. Kegalle